Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Most Doubt the Trump Administration Will Lower Drug Costs for People Like Them, Though Three-Fourths of Republicans Expect It Will About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds
PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with flat pricing your dose may go up, but your price won't
Pick the format youll actually take every day
Huang T, Zhang K, Sun L, et al
This page is an educational research-context reference
FDA Control Over Salt Forms Versus Base Ingredient The FDA has made clear that the active ingredient in approved medications such as Wegovy and Ozempic is semaglutide in its base form